Angiotensin-Converting Enzyme Inhibitor / Angiotensin II Receptor Blocker in COVID-19: a Double-edged Sword or a Myth. Nep. Med. J. [Internet]. 2020 May 27 [cited 2026 Jul. 9];3(1):309-12. Available from: https://www.nepjol.info/index.php/nmj/article/view/28726